ORYZON Reports Results and Corporate Update for First Half Ended June 30, 2021

NEXT STORY
AB Science announced that results from its Phase 3 AB09004 study on mild to moderate Alzheimer’s disease have been presented at the AAIC
PREV STORY
Onxeo Announces the Appointment of Dr. Shefali Agarwal as the Company’s Chairwoman of the Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients

Survival rate of 68% from first patient cohort vs published historical rate of 30-53% ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Poster Presentation at the 2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

TEL-AVIV, Israel and RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News

Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights

-- Dosing Underway in Phase 1 Clinical Trial of EDP1066 in Psoriasis and Atopic ...

author_avatar
NASDAQ Market News